REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,059,000 | +180.8% | 213,808 | +149.1% | 0.21% | +163.0% |
| Q3 2020 | $2,158,000 | +3.0% | 85,840 | 0.0% | 0.08% | +1.2% |
| Q2 2020 | $2,096,000 | +65.0% | 85,840 | 0.0% | 0.08% | +40.4% |
| Q1 2020 | $1,270,000 | -8.8% | 85,840 | 0.0% | 0.06% | +7.5% |
| Q4 2019 | $1,393,000 | -28.0% | 85,840 | +10.2% | 0.05% | -24.3% |
| Q3 2018 | $1,936,000 | -9.5% | 77,919 | 0.0% | 0.07% | -13.6% |
| Q2 2018 | $2,139,000 | +60.2% | 77,919 | +79.8% | 0.08% | +55.8% |
| Q1 2018 | $1,335,000 | +15.9% | 43,329 | +34.5% | 0.05% | +18.2% |
| Q4 2017 | $1,152,000 | -5.3% | 32,225 | -57.0% | 0.04% | -6.4% |
| Q3 2016 | $1,216,000 | +19.2% | 75,000 | 0.0% | 0.05% | +11.9% |
| Q2 2016 | $1,020,000 | +29.8% | 75,000 | +66.7% | 0.04% | +27.3% |
| Q1 2016 | $786,000 | – | 45,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |